Participation by More Than 30 New Zealand Companies at BIO 2004 Highlights the Global Reach of New Zealand's Biotechnology Industry.Business Editors/Health/Medical Writers BIOWIRE2K BIO 2004 Annual Convention AUCKLAND, New Zealand--(BUSINESS WIRE)--June 1, 2004 New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. Presence to Showcase the Nation's Capabilities in Human Health, Agbiotech and Industrial Biotechnology The references in this article would be clearer with a different and/or consistent style of citation, footnoting or external linking. Industrial biotechnology (known mainly in Europe as white biotechnology Applications With its highest-caliber bioscience, unique genetic diversity, agricultural tradition, the best animal health status in the world and welcoming research and development environment, New Zealand today is home to one of the fastest growing biotechnology industries in the world. The nation is quickly emerging as a globally connected center for biotechnology research and development, not only in agbiotech and human health care, but also in industrial production, environmental applications and animal health. To promote awareness of New Zealand's growing global presence in biotechnology, the Honorable Peter Hodgson, Minister of Research, Science and Technology, will lead a New Zealand biotech industry delegation of more than 30 companies to the BIO 2004 conference, taking place from June 6-9 in San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] , USA. Through its internationally oriented biotech industry and its presence at BIO 2004, New Zealand is reaching out to partner with leading U.S. research institutes and universities, companies, and state agencies to further the growth of biotechnology worldwide. New Zealand Biosphere biosphere, irregularly shaped envelope of the earth's air, water, and land encompassing the heights and depths at which living things exist. The biosphere is a closed and self-regulating system (see ecology), sustained by grand-scale cycles of energy and of Pavilion New Zealand Trade and Enterprise (NZTE NZTE New Zealand Trade and Enterprise ) will host a pavilion, New Zealand Biosphere, at the BIO 2004 Exhibit Hall. This year's pavilion will showcase a variety of New Zealand human health, agbiotech, industrial biotech and support organizations through multiple company displays that demonstrate New Zealand's critical mass of applicable biotechnologies. The pavilion will include a dedicated meeting area for networking and one-on-one meetings during the conference. NZTE will co-host an exhibit hall event on Tuesday June 8, 2:00 - 4:00 pm, featuring wine & cheese from New Zealand. New Zealand Companies This is a list of major companies based in New Zealand. For convenience, the word "Limited", which every company registered or reregistered under the Companies Act 1993 (with one historic exception) must have at the end of its name, is reduced to the common and universally at BIO 2004 A wide variety of New Zealand's leading biotech companies, research organisations and support service providers will represent the nation's outstanding capabilities and global reach at BIO 2004, including: -- CoDa Therapeutics - Formed by researchers from University College London and Auckland University in New Zealand, CoDa has a unique approach to wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by with broad applications demonstrated in pre-clinical trials. Its antisense antisense, DNA or RNA manipulated in a laboratory so that its components (nucleotides) form a complementary copy of normal, or "sense," messenger RNA (mRNA; see nucleic acid). technology has many potential indications, ranging from skins lesions to treatment of the cornea cornea: see eye. of the eye after laser surgery. -- IRL 1. (jargon, chat) IRL - In real life. Generally synonymous with f2f. 2. (language, robotics) IRL - Industrial Robot Language. - Nurturing biotechnologies and materials science materials science Study of the properties of solid materials and how those properties are determined by the material's composition and structure, both macroscopic and microscopic. , Industrial Research Ltd (IRL) converts New Zealand science into globally competitive products for customers worldwide. A collaboration between IRL and the Albert Einstein College of Medicine in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of has produced potent new enzyme inhibitors called "Immucillins" to treat T-cell cancers, autoimmune diseases, and prevent organ transplant rejection. -- Ovita, a consortium of AgResearch, Meat New Zealand and the New Zealand Wool Board, is exploiting well-characterized genetic traits and protein biomarkers discovered through decades of sheep breeding in New Zealand. Ovita research focuses on livestock parasites, diseases, muscle development and reproduction. BIO Business Forum Two New Zealand biotech companies -- AgriGenesis and Pacific Edge Biotechnology Ltd -- will be presenting at the BIO Business Forum, a corporate partnering showcase at BIO 2004. -- AgriGenesis - A key goal of AgriGenesis is to develop new plant products that can replace products currently derived from fossil fuels, including designer biofuel bi·o·fuel n. Fuel such as methane produced from renewable resources, especially plant biomass and treated municipal and industrial wastes. bi crops that make plant-to-ethanol conversion economically viable. -- Pacific Edge Biotechnology Ltd , a biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company with a strategic focus on 'Human Health and Wellness,' combines state-of-the-art molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and microarray technology with world-class tissue banks and clinical data. These resources, combined with proprietary analytical software, enable the company to identify unique gene signatures of disease. Ministerial Seminar Mr. Hodgson will speak at the international Ministerial Seminar, a forum for government-to-government networking, on New Zealand's strengths, challenges, and recent initiatives to grow R&D and manufacturing. "With one of the fastest-growing biotechnology sectors in the world, New Zealand is an eager and fertile contributor to the growing globalization globalization Process by which the experience of everyday life, marked by the diffusion of commodities and ideas, is becoming standardized around the world. Factors that have contributed to globalization include increasingly sophisticated communications and transportation of biotechnology," said Mr. Hodgson. "Science and innovation are central to this Government's ambitions for both the economy and the environment. We've put our money where our mouth is through public investment in research, science and technology over the past several years. Investing in R&D is what smart economies do." Australia and New Zealand Biotech Alliance The New Zealand and Australian biotech sectors are highly collaborative with around 60 joint projects underway, ranging from research on new therapeutics and sheep genomics to the development of animal pharmaceuticals. The Biotech Alliance between New Zealand and the Australian states will see the members jointly marketing New Zealand and Australian biotechnology to the world. Cooperation between the two countries at BIO -- the New Zealand and Australian stands are side by side -- is an example of the alliance in action. On June 5th, there will be a formal signing, recognizing New Zealand's membership in this trans-national alliance. About New Zealand Trade & Enterprise New Zealand Trade and Enterprise (NZTE) is the New Zealand Government's agency charged with helping New Zealand businesses achieve success at in the global marketplace and at home by improving their capability and international competitiveness. NZTE provides market intelligence and market development services through a network of 48 offices in New Zealand and around the world. This global capability is aligned with local strategies to develop sectors, such as biotech, from a national and regional perspective, while assisting individual firms to improve their capabilities to take up these new opportunities. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion